Akari Therapeutics Plc (AKTX)

0.2609 +0.01 (+2.31%) USD  |  NASDAQ  |  Feb 25, 16:00
0.2677 +0.01 (+2.61%) Pre-Market: 20:00
More

Akari Therapeutics Interest Paid Supplemental Data (Quarterly)

Interest Paid Supplemental Data (Quarterly) Chart

View Interest Paid Supplemental Data (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (Quarterly) Benchmarks

View Interest Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade